These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 21710641

  • 1. Flow cytometric assay using two fluorescent proteins for the function of the internal ribosome entry site of hepatitis C virus.
    Shi G, Yagyu F, Shimizu Y, Shimizu K, Oshima M, Iwamoto A, Gao B, Liu W, Gao GF, Kitamura Y.
    Cytometry A; 2011 Aug; 79(8):653-60. PubMed ID: 21710641
    [Abstract] [Full Text] [Related]

  • 2. Involvement of proteasome alpha-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated translation.
    Krüger M, Beger C, Welch PJ, Barber JR, Manns MP, Wong-Staal F.
    Mol Cell Biol; 2001 Dec; 21(24):8357-64. PubMed ID: 11713272
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of internal ribosomal entry site-directed translation of HCV by recombinant IFN-alpha correlates with a reduced La protein.
    Shimazaki T, Honda M, Kaneko S, Kobayashi K.
    Hepatology; 2002 Jan; 35(1):199-208. PubMed ID: 11786977
    [Abstract] [Full Text] [Related]

  • 4. A peptide derived from RNA recognition motif 2 of human la protein binds to hepatitis C virus internal ribosome entry site, prevents ribosomal assembly, and inhibits internal initiation of translation.
    Pudi R, Ramamurthy SS, Das S.
    J Virol; 2005 Aug; 79(15):9842-53. PubMed ID: 16014945
    [Abstract] [Full Text] [Related]

  • 5. Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway.
    Kato J, Kato N, Moriyama M, Goto T, Taniguchi H, Shiratori Y, Omata M.
    J Infect Dis; 2002 Jul 15; 186(2):155-63. PubMed ID: 12134250
    [Abstract] [Full Text] [Related]

  • 6. Nucleotide sequence variations in the internal ribosome entry site of hepatitis C virus-1b: no association with efficacy of interferon therapy or serum HCV-RNA levels.
    Yamamoto C, Enomoto N, Kurosaki M, Yu SH, Tazawa J, Izumi N, Marumo F, Sato C.
    Hepatology; 1997 Dec 15; 26(6):1616-20. PubMed ID: 9398006
    [Abstract] [Full Text] [Related]

  • 7. A cell-based bicistronic lentiviral reporter system for identification of inhibitors of the hepatitis C virus internal ribosome entry site.
    Lourenço S, Boni S, Furling D, Cosset FL, Cahour A.
    J Virol Methods; 2009 Jun 15; 158(1-2):152-9. PubMed ID: 19428584
    [Abstract] [Full Text] [Related]

  • 8. Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation.
    Dash S, Prabhu R, Hazari S, Bastian F, Garry R, Zou W, Haque S, Joshi V, Regenstein FG, Thung SN.
    Liver Int; 2005 Jun 15; 25(3):580-94. PubMed ID: 15910496
    [Abstract] [Full Text] [Related]

  • 9. Cap and polyA tail enhance translation initiation at the hepatitis C virus internal ribosome entry site by a discontinuous scanning, or shunting, mechanism.
    Wiklund L, Spångberg K, Goobar-Larsson L, Schwartz S.
    J Hum Virol; 2001 Jun 15; 4(2):74-84. PubMed ID: 11437317
    [Abstract] [Full Text] [Related]

  • 10. Down-regulation of the internal ribosome entry site (IRES)-mediated translation of the hepatitis C virus: critical role of binding of the stem-loop IIId domain of IRES and the viral core protein.
    Shimoike T, Koyama C, Murakami K, Suzuki R, Matsuura Y, Miyamura T, Suzuki T.
    Virology; 2006 Feb 20; 345(2):434-45. PubMed ID: 16297950
    [Abstract] [Full Text] [Related]

  • 11. Roles of the polypyrimidine tract and 3' noncoding region of hepatitis C virus RNA in the internal ribosome entry site-mediated translation.
    Wang H, Shen XT, Ye R, Lan SY, Xiang L, Yuan ZH.
    Arch Virol; 2005 Jun 20; 150(6):1085-99. PubMed ID: 15747050
    [Abstract] [Full Text] [Related]

  • 12. Increased inhibitory ability of conjugated RNA aptamers against the HCV IRES.
    Kikuchi K, Umehara T, Nishikawa F, Fukuda K, Hasegawa T, Nishikawa S.
    Biochem Biophys Res Commun; 2009 Aug 14; 386(1):118-23. PubMed ID: 19501043
    [Abstract] [Full Text] [Related]

  • 13. Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro.
    Alotte C, Martin A, Caldarelli SA, Di Giorgio A, Condom R, Zoulim F, Durantel D, Hantz O.
    Antiviral Res; 2008 Dec 14; 80(3):280-7. PubMed ID: 18625270
    [Abstract] [Full Text] [Related]

  • 14. Human ribosomal protein L18a interacts with hepatitis C virus internal ribosome entry site.
    Dhar D, Mapa K, Pudi R, Srinivasan P, Bodhinathan K, Das S.
    Arch Virol; 2006 Mar 14; 151(3):509-24. PubMed ID: 16195786
    [Abstract] [Full Text] [Related]

  • 15. Differential effects on the hepatitis C virus (HCV) internal ribosome entry site by vitamin B12 and the HCV core protein.
    Li D, Lott WB, Martyn J, Haqshenas G, Gowans EJ.
    J Virol; 2004 Nov 14; 78(21):12075-81. PubMed ID: 15479850
    [Abstract] [Full Text] [Related]

  • 16. Hepatitis C virus (HCV) NS2 protein up-regulates HCV IRES-dependent translation and down-regulates NS5B RdRp activity.
    She Y, Liao Q, Chen X, Ye L, Wu Z.
    Arch Virol; 2008 Nov 14; 153(11):1991-7. PubMed ID: 18853100
    [Abstract] [Full Text] [Related]

  • 17. Internal initiation of translation of hepatitis C virus RNA: the ribosome entry site is at the authentic initiation codon.
    Reynolds JE, Kaminski A, Carroll AR, Clarke BE, Rowlands DJ, Jackson RJ.
    RNA; 1996 Sep 14; 2(9):867-78. PubMed ID: 8809014
    [Abstract] [Full Text] [Related]

  • 18. The pathway of HCV IRES-mediated translation initiation.
    Otto GA, Puglisi JD.
    Cell; 2004 Oct 29; 119(3):369-80. PubMed ID: 15507208
    [Abstract] [Full Text] [Related]

  • 19. Targeting internal ribosome entry site (IRES)-mediated translation to block hepatitis C and other RNA viruses.
    Dasgupta A, Das S, Izumi R, Venkatesan A, Barat B.
    FEMS Microbiol Lett; 2004 May 15; 234(2):189-99. PubMed ID: 15135522
    [Abstract] [Full Text] [Related]

  • 20. Efficient ablation by immunotoxin-mediated cell targeting of the cell types that express human interleukin-2 receptor depending on the internal ribosome entry site.
    Kobayashi T, Kida Y, Kaneko T, Pastan I, Kobayashi K.
    J Gene Med; 2001 May 15; 3(5):505-10. PubMed ID: 11601764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.